Evidence map›Paper›PMID 40784883›Full record

ArticleScientific reports2025

Deep learning and radiomics fusion for predicting the invasiveness of lung adenocarcinoma within ground glass nodules.

Qian Sun, Lei Yu, Zhongquan Song, Can Wang, Wei Li, Wang Chen, Juan Xu, Shuhua Han

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qian SunDepartment of Pulmonary and Critical Care Medicine, Medical School, Zhongda Hospital, Southeast University, No. 87 Dingjia Bridge, Nanjing, 210009, Jiangsu, China.
Lei YuDepartment of Radiology, The First People's Hospital of Yancheng, Yancheng No.1 People's Hospital, Affiliated Hospital of Medical School, Nanjing University, Yancheng, 224006, China.
Zhongquan SongDepartment of Pulmonary and Critical Care Medicine, Medical School, Zhongda Hospital, Southeast University, No. 87 Dingjia Bridge, Nanjing, 210009, Jiangsu, China.
Can WangDepartment of Respiratory Medicine, The First People's Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical University, No. 66 Renmin South Road, Yancheng, 224006, China.
Wei LiDepartment of Respiratory Medicine, The First People's Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical University, No. 66 Renmin South Road, Yancheng, 224006, China.
Wang ChenDepartment of Radiology, The First People's Hospital of Yancheng, Yancheng No.1 People's Hospital, Affiliated Hospital of Medical School, Nanjing University, Yancheng, 224006, China.
Juan XuDepartment of Respiratory Medicine, The First People's Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical University, No. 66 Renmin South Road, Yancheng, 224006, China. xujuanycyy@163.com.
Shuhua HanDepartment of Pulmonary and Critical Care Medicine, Medical School, Zhongda Hospital, Southeast University, No. 87 Dingjia Bridge, Nanjing, 210009, Jiangsu, China. hanshuhua0922@126.com.

Funding

The 2024 Medical Research Program of the Yancheng Municipal Health Commission YK2024015The Medical Empowerment Public Welfare Special Fund of the Chinese Red Cross Foundation (2022 Leading Elite Clinical Research Project) XM_LHJY2022_05_33
6 · The paper itself

Abstract

Microinvasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC) require distinct treatment strategies and are associated with different prognoses, underscoring the importance of accurate differentiation. This study aims to develop a predictive model that combines radiomics and deep learning to effectively distinguish between MIA and IAC. In this retrospective study, 252 pathologically confirmed cases of ground-glass nodules (GGNs) were included, with 177 allocated to the training set and 75 to the testing set. Radiomics, 2D deep learning, and 3D deep learning models were constructed based on CT images. In addition, two fusion strategies were employed to integrate these modalities: early fusion, which concatenates features from all modalities prior to classification, and late fusion, which ensembles the output probabilities of the individual models. The predictive performance of all five models was evaluated using the area under the receiver operating characteristic curve (AUC), and DeLong's test was performed to compare differences in AUC between models. The radiomics model achieved an AUC of 0.794 (95% CI: 0.684-0.898), while the 2D and 3D deep learning models achieved AUCs of 0.754 (95% CI: 0.594-0.882) and 0.847 (95% CI: 0.724-0.945), respectively, in the testing set. Among the fusion models, the late fusion strategy demonstrated the highest predictive performance, with an AUC of 0.898 (95% CI: 0.784-0.962), outperforming the early fusion model, which achieved an AUC of 0.857 (95% CI: 0.731-0.936). Although the differences were not statistically significant, the late fusion model yielded the highest numerical values for diagnostic accuracy, sensitivity, and specificity across all models. The fusion of radiomics and deep learning features shows potential in improving the differentiation of MIA and IAC in GGNs. The late fusion strategy demonstrated promising results, warranting further validation in larger, multicenter studies.

Indexed as

Adenocarcinoma of LungDeep LearningLung NeoplasmsAgedFemaleHumansMaleMiddle AgedNeoplasm InvasivenessRadiomicsRetrospective StudiesROC CurveTomography, X-Ray ComputedDeep learningFusion modelGround-glass noduleInvasive adenocarcinomaRadiomics

Identifiers

PMID40784883
PMCPMC12336349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.